Ozempic’s maker is in trouble. Tablets may be the answer
Just a few years ago, Novo Nordisk was the darling of the healthcare industry. Now it is teetering.
We haven't written up this one. The Sydney Morning Herald has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- Ozempic’s maker is in trouble. Tablets may be the answer theage.com.au